Stay updated on PembROlizuMab vs Chemo in MPM Clinical Trial
Sign up to get notified when there's something new on the PembROlizuMab vs Chemo in MPM Clinical Trial page.

Latest updates to the PembROlizuMab vs Chemo in MPM Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check19 days agoChange DetectedThe page's revision label was updated from v3.5.3 to v3.5.4, indicating a software release rather than a change to the study details.SummaryDifference0.0%

- Check26 days agoNo Change Detected
- Check40 days agoChange DetectedThe page’s revision/version label was updated from **Revision: v3.5.0** to **Revision: v3.5.3**.SummaryDifference0.0%

- Check76 days agoChange DetectedPage revision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check90 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check112 days agoChange DetectedRevision: v3.4.2 was added and Revision: v3.4.1 was removed. This appears to be a minor maintenance update with no impact on study details or user-visible information.SummaryDifference0.0%

- Check119 days agoChange DetectedAdded the VANTAGE-014 publication reference (Lancet Oncology, 2015) and updated to revision v3.4.1 in the Publications section; removed the Lancet Oncology erratum and the prior revision (v3.4.0).SummaryDifference0.1%

Stay in the know with updates to PembROlizuMab vs Chemo in MPM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PembROlizuMab vs Chemo in MPM Clinical Trial page.